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Abstract
Background: Molecular structures can be represented as strings of special characters using SMILES. Since each
molecule is represented as a string, the similarity between compounds can be computed using SMILES-based string
similarity functions. Most previous studies on drug-target interaction prediction use 2D-based compound similarity
kernels such as SIMCOMP. To the best of our knowledge, using SMILES-based similarity functions, which are
computationally more efficient than the 2D-based kernels, has not been investigated for this task before.
Results: In this study, we adapt and evaluate various SMILES-based similarity methods for drug-target interaction
prediction. In addition, inspired by the vector space model of Information Retrieval we propose cosine similarity based
SMILES kernels that make use of the Term Frequency (TF) and Term Frequency-Inverse Document Frequency (TF-IDF)
weighting approaches. We also investigate generating composite kernels by combining our best SMILES-based
similarity functions with the SIMCOMP kernel. With this study, we provided a comparison of 13 different ligand
similarity functions, each of which utilizes the SMILES string of molecule representation. Additionally, TF and TF-IDF
based cosine similarity kernels are proposed.
Conclusion: The more efficient SMILES-based similarity functions performed similarly to the more complex 2D-based
SIMCOMP kernel in terms of AUC-ROC scores. The TF-IDF based cosine similarity obtained a better AUC-PR score than
the SIMCOMP kernel on the GPCR benchmark data set. The composite kernel of TF-IDF based cosine similarity and
SIMCOMP achieved the best AUC-PR scores for all data sets.
Keywords: Chemoinformatics, SMILES, SMILES based drug similarity, Drug-target interaction prediction
Background
Identification of potential interactions between target
proteins and drugs is a difficult task and computer sci-
entists and medicinal chemists alike consider it a chal-
lenge before the whole drug discovery field. Efficient
prediction of target-compound interactions using com-
putational methods accelerates research efforts in this
area. There have been two generally accepted approaches
to drug discovery, ligand-based and structure-based or
docking [1]. Ligand-based approaches are based on the
known ligands of a protein and lack applicability when
the target has no known ligands (orphan target), while
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structure-based approaches utilize the three dimensional
structure of the target, if it is known [1]. Literature min-
ing, where interacting genes and compounds are extracted
from the related articles, can also be used [2]. Chemoge-
nomics relates the chemical properties of ligands with
the sequence properties of proteins, with the final goal
of protein-ligand interaction prediction. The underlying
assumption is that chemically similar compounds will
bind to the same or similar proteins and that targets with
similar binding sites should also bind to the same ligands
[3]. In this work, we combine protein sequence similarity
and ligand chemical similarity information for protein-
drug interaction prediction using machine learning. Our
main goal is to evaluate the performance of different lig-
and similarity functions that utilize their SMILES strings
for this task.
© 2016 Öztürk et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Chemogenomics has three main components: (i) set of
compounds (ii) set of targets (iii) reliable interaction infor-
mation [4]. Recent studies have adopted chemogenomics
approaches for predicting drug-target interactions [5–17]
based on genomic similarity of proteins and/or chemical
similarity of ligands using different computational mod-
els and classification algorithms. One of the first studies
utilizing machine learning methods for ligand-based vir-
tual screening tested different target kernels with Support
Vector Machines (SVM). Three different protein data sets
were examined to predict drugs even for targets with
no known ligands using the similarity between proteins
[6]. The same year, chemical compound similarity and
protein sequence similarity were used to propose three
different profile kernel methods by Yamanishi et al. for
interaction prediction [5]. The database of drug-target
interactions curated in this work is commonly used as
a reference/benchmark data set [5]. Gaussian Interaction
Profile (GIP) kernel, introduced by Laarhoven et al., was
built on binary vectors named interaction profiles that are
defined for each drug and protein in the data set [16].
The interaction profile of a drug indicates its interaction
status (present (1)/ absent (0)) with every target in the
data set. Similarly, the interaction profile of a target is a
binary vector representing its interaction status with all
the drugs in the data set. The model was later improved
using the Weighted Nearest Neighbor algorithm (WNN-
GIP), so that it was possible to make predictions for
new drug compounds by predicting their interaction
profiles [17].
The chemical similarity of ligands can be based on the
1D, 2D, and 3D representations of molecules [4]. The
most commonly used descriptors are based on 2D and
3D representations of the compounds [18–22]. A detailed
comparison of different chemical descriptors and 2D
graph similarity kernels used in predicting protein-drug
interactions was recently reported in [23]. A popular 1D
representation for molecular structures is the Simpli-
fied Molecular Input Line Entry System (SMILES) that
describes molecular structures in the form of strings
[24, 25]. SMILES strings convey information about
molecular structures by using symbols such as C, c, N,
O for atoms and =, # for bonds (www.daylight.com/
dayhtml/doc/theory/theory.smiles.html). The SMILES
representation has been used to obtain molecular sim-
ilarity for purposes such as toxicity prediction, virtual
screening, and Quantitative structure-activity relation-
ship (QSAR) modelling [26–30]. To the best of our
knowledge, SMILES strings have not been previously
used to represent similarities among compounds for the
task of drug-target interaction prediction. Most previous
studies on drug-target interaction prediction make use of
the more complex 2D representations of the compounds
such as SIMCOMP.
In this study, we seek to answer whether a SMILES rep-
resentation based compound similarity method can per-
form as well as the widely used 2D representation based
similarity method, SIMCOMP [31], in the drug-target
interaction prediction task. The methods we discussed
in this paper can be used in any drug-target interac-
tion prediction algorithm that makes use of the com-
pound similarity information. For evaluation purposes,
we use one of the state-of-the-art algorithms for drug-
target interaction prediction, namely the Weighted Near-
est Neighbor-Gaussian Interaction Profile (WNN-GIP)
model proposed in [17] and we use the benchmark data
sets curated by Yamanishi et al.; GPCRs, enzymes, nuclear
receptors, ion channels, and their interacting ligands [5].
We adapt and evaluate various string similarity functions,
which are based on the SMILES representations of the
ligands, for the task of drug-target interaction predic-
tion. The string similarity methods that we utilize include
edit distance [32], normalized longest common subse-
quence (NLCS), and amodel that combines three different
longest common subsequence (LCS) [33] algorithms, as
well as SMILES specialized algorithms such as LINGO
[26], SMILES fingerprint (SMIfp) [28], and SMILES-
based substring kernel [27]. We also present two novel
models that combine the LINGO representation with
the term frequency (TF) weighting and term frequency-
inverse document frequency (TF-IDF) weighting schemes
adopted from the Information Retrieval domain. In addi-
tion, two composite kernels are constructed by combining
the 2D-based similarity kernel SIMCOMP with TF-IDF
based cosine similarity kernel and LINGOsim kernel. Our
results show that SMILES-based similarity kernels per-
form close to the 2D-based similarity kernel, SIMCOMP,
at a fraction of the computational time. The composite
kernel comprising the SMILES-based TF-IDF cosine simi-
larity kernel and 2D-based SIMCOMPkernel obtained the
best performance in terms of AUC-PR scores for all data
sets.
Methods
In this section we first describe the data sets that we used
for evaluation and the drug-target interaction predic-
tion algorithm (i.e., Weighted Nearest Neighbor-Gaussian
Interaction Profile (WNN-GIP) [17]), into which we inte-
grated the SMILES-based compound similarity functions.
Next, we present the SMILES-based compound similar-




We used the benchmark drug-target interaction data sets
for enzymes, ion channels, GPCRs, and nuclear recep-
tors provided by Yamanishi et al. [5] for evaluation. The
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data sets are publicly available at http://web.kuicr.kyoto-
u.ac.jp/supp/yoshi/drugtarget/. Yamanishi et al. retrieved
the interaction information between target proteins and
compounds from the KEGG BRITE [34], BRENDA [35],
SuperTarget [36], and DrugBank [37] databases. The
properties of the interaction data sets are provided in
Table 1.
Genomic data
Target proteins are retrieved from the KEGG GENES
database [34], and the normalized version of the Smith-
Waterman score is used to calculate the similarity between
the amino-acid sequences of the target proteins [5].
Chemical data
The DRUG and COMPOUND sections of KEGG DRUG
database [34] are used to obtain the chemical struc-
tures. SIMCOMP is used to construct the original com-
pound similarity matrix [5]. SIMCOMP treats chemical
molecules as graphs, then produces a score represent-
ing the similarity between two graphs [31, 38]. In order
to calculate our own compound similarity matrices, we
first downloaded the MOL files from KEGG DRUG for
each of the compounds included in the data sets. Then,
we used JChem 6.0.2 for .NET (ChemAxon, https://www.
chemaxon.com/) to convert the MOL files into unique
SMILES strings [25].
Prediction algorithm
We used the WNN-GIP drug-target interaction pre-
diction model [16, 17] in order to compare the
different SMILES string based compound similarity
methods.WNN-GIP requires a bipartite drug-target inter-
action network, which is represented as an adjacency
matrix in which a cell is set to 1 if the drug and the tar-
get interact, and to 0 otherwise. Each row of the adjacency
matrix corresponds to the interaction profile of a drug and
each column corresponds to the interaction profile of a
target. The interaction profiles of the drugs and targets,
as well as the chemical similarity information of the com-
pounds and the genomic similarity information of the pro-
teins are provided as inputs to the WNN-GIP algorithm.
First, the kernels for the drugs and targets are created from
the chemical similarity and genomic similarity informa-
tion, respectively by modifying their similarity matrices
Table 1 Number of components included in the drug-target
interaction data sets of Yamanishi et al. [5]
Dataset Drugs Targets Interactions
Enzyme 445 664 2926
Ion Channels 210 204 1476
GPCR 223 95 635
Nuclear Receptor 54 26 90
so that they become symmetric and positive definite (i.e.,
well-defined kernel functions). Then, the Gaussian kernel
is used to construct a kernel from the interaction pro-
files, which is combined with the chemical kernel and the
genomic kernel. Finally, the Kronecker product is used to
merge the kernel for drugs and the kernel for targets into
a kernel directly representing drug-target pairs. The Reg-
ularized Least Squares (RLS) algorithm is employed for
the prediction of drug target interactions [16]. In the orig-
inal study, WNN-GIP used the SIMCOMP method based
on the 2D representation of the compounds to compute
the compound chemical similarity scores. In this study,
we investigated using the computationally more efficient
1D SMILES-based similarity functions to compute the
compound similarity scores instead of SIMCOMP in the
WNN-GIP algorithm.
SMILES-based compound similarity functions
In this sub-section we provide the methods that
we adopted and evaluated to measure the similar-
ity of compounds using their SMILES string repre-
sentations. The source code comprising the SMILES-
based similarity algorithms discussed in this section
is publicly available at: https://github.com/hkmztrk/
SMILESbasedSimilarityKernels.
All SMILES strings are modified such that atoms rep-
resented with two characters such as ‘Cl’ and ‘Br’ are
replaced with single characters. For illustration purposes,
we use the imaginary SMILES strings SMI1: “OC(O)=O”
and SMI2: “CCCCC(O)=C4” to demonstrate the SMILES-
based similarity methods.
Edit distance
Edit distance is one of the most widely used measures to
make comparisons between strings. Given two strings S1
and S2, the edit distance between them is defined as the
number of minimum edit operations required to convert
S1 into S2 [39]. There are three main operations allowed,
namely insertion, deletion, and substitution [39]. For our
samples, edit(SMI1, SMI2) = 6. In order to convert SMI1
to SMI2, we have to perform four insertion operations
(for inserting three characters “C” and for inserting one
character “4”), and two substitution operations (for substi-
tuting the first and last “O” with “C”) . Then, the similarity
is calculated as,
EditSim(SMI1, SMI2) = 1 − edit(SMI1, SMI2)MAX(length(SMI1), length(SMI2))
Normalized longest common subsequence (NLCS)
The Longest Common Subsequence (LCS) algorithm
finds the common subsequence with the maximum pos-
sible length of two strings [40]. The algorithm does not
require the characters in the common subsequence to be
consecutive. Normalized LCSmodifies the algorithm such
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that the lengths of both strings are considered. Given two
strings S1 and S2 the NLCS is [33],
NLCS(S1, S2) = length (LCS (S1, S2))
2
length (S1) × length (S2)
For our sample SMILES strings, the longest common
subsequence is “C(O)=”. Therefore,
NLCS (SMI1, SMI2) = 0.32
Combination of LCSmodels (CLCS)
Islam and Inkpen proposed a method to measure seman-
tic similarity of the texts by combining three algorithms
each of which modifies the LCS algorithm in a different
way [33].Wewill refer to this method as CLCS throughout
the paper. The first algorithm is Normalized LCS (NLCS),
described in the previous section. The second algorithm
is called Maximal Consecutive Longest Common Subse-
quence starting from the character 1,MCLCS1. It requires
the common subsequences to be consecutive and to start
from the first index of the shorter string. The last algo-
rithm is named Maximal Consecutive Longest Common
Subsequence starting from character n, MCLCSn [33].
Similarly toMCLCS1,MCLCSn requires the common sub-
sequences to be successive. However unlikeMCLCS1, the
consecutive symbols don’t have to start from the first
index in theMCLCSn, i.e, they can start from any position
in the string. MCLCS1 and MCLCSn are also normalized
and named as NMCLCS1 and NMCLCSn, respectively.
Given two strings S1 and S2,NMCLCS1 andNMCLCSn are
calculated as [33],
NMCLCS1(S1, S2) = length (MCLCS1 (S1, S2))
2
length (S1) × length (S2)
NMCLCSn(S1, S2) = length (MCLCSn (S1, S2))
2
length(S1) × length(S2)
In order to compute the similarity between S1 and S2,
the weighted sum of these three algorithms is taken as
follows [33]:
K(S1, S2) = v1 ×w1 + v2 ×w2 + v3 ×w3, where w1, w2,
w3 are the weights and
v1 = NLCS (S1, S2)
v2 = NMCLCS1 (S1, S2)
v3 = NMCLCSn (S1, S2)
The original method gives each algorithm the same
weight (w1 = w2 = w3 = 0.33)[33].
Let us demonstrate this model with our sam-
ple SMILES strings. For the first algorithm,
NLCS(SMI1, SMI2) = 0.32. NMCLCS1 requires the
longest common subsequence to be consecutive and
to start from the first index, which is equal to “O” and
therefore, NMCLCS1 (SMI1, SMI2) = 0.012. For
NMCLCSn, the longest common subsequence is “C(O)=”.
NMCLCSn (SMI1, SMI2) = 0.32. Finally, the similarity
score becomes 0.218.
SMILES representation-based string kernel
SMILES representation-based string kernel is proposed as
a compound similarity kernel and combined with SVM to
predict in silico toxicity of the compounds in [27]. Given
two SMILES texts S1 and S2, θ (S1) and θ (S2) respectively
denote the frequencies of all the possible substrings with
at least q = 2 character length. The string similarity kernel
is defined as the inner product of these frequencies [27].
K (S1, S2) = 〈θ (S1) , θ (S2)〉
Consider our sample SMILES strings SMI1 and SMI2.
The frequency of each SMI1 substring, {OC, C(, (O, . . . ,
OC(, C(O, . . . , OC(O, C(O), . . . , OC(O), C(O)=, (O)=O,
OC(O)=, C(O)=O, OC(O)=O }, is 1. The frequency
of the SMI2 substrings {C(, (O, O), . . . ,CC(, C(O,. . . ,
CCCCC(O)=C, CCCC(O)=C4, CCCCC(O)=C4 } is also
1 except for the SMI2 substrings {CC, CCC, CCCC }
that have frequencies of 4, 3, and 2, respectively. The
shared substrings from these sets are, {C(, (O, O), )=, C(O,
(O), O)=, C(O), (O)=, C(O)= }, all of which have a fre-
quency of 1. Therefore, the inner product,K (SMI1, SMI2),
is 10.
SMILES fingerprint (SMIfp)
SMILES Fingerprint (SMIfp) was introduced by Schwartz
et al. to perform ligand-based virtual screening [28].
SMIfp is based on representing SMILES strings in a 34-
dimensional space where each of the dimensions corre-
spond to the frequency of a different symbol such as
C, c, N, and # [28]. More than 32 million compounds
in PubChem are analyzed in order to identify the most-
frequent symbols in a SMILES string to form the best-
representative scalar fingerprint and as a result, 34 rele-
vant symbols are selected. Once SMILES strings are con-
verted to scalar fingerprints, City Block Distance (CBD)
[41] is used to measure similarities. Aside from CBD, we
use Tanimoto coefficient to observe whether the distance
metric affects the performance of the model.
CBD treats the common absence or low values of fea-
tures as an indication of similarity, whereas Tanimoto
does not [18]. On the other hand, unlike CBD, Tanimoto
considers size normalization. For the chemical domain,
Tanimoto is recommended to be used to measure the
absolute similarity between two molecules, whereas CBD
and Euclidian distance are useful to measure relative sim-
ilarity, i.e. the relative similarities of two molecules to the
some other molecule [42].
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LINGO
LINGO refers to q-character substrings of a SMILES
text [26]. LINGO representation of compounds has been
used as input for Quantitative Structure-Property Rela-
tionships (QSPR) models as well as for calculation of
intermolecular similarities. A SMILES string of length n
can be represented with (n− (q − 1)) q-length substrings
(LINGOs). The original method requires SMILES strings
to be canonical, and LINGO length is fixed as q = 4.
Before the LINGO creation process, all ring numbers in
the SMILES string are set to ‘0’. Then, the LINGOsim
function is used to calculate the similarity between two
SMILES strings S1 and S2 with the Tanimoto coefficient








where m is the total number of unique LINGOs created
from S1 and S2, while NS1,i represents the frequency of
LINGOs of type i in compound S1 andNS2,i represents the
frequency of LINGOs of type i in compound S2.
Let us demonstrate how compound similarity is calcu-
lated using the LINGO model with our sample strings,
SMI1 and SMI2. SMI1: “OC(O)=O” doesn’t require any
modification, whereas for SMI2: “CCCCC(O)=C4” we
have to set ring numbers to 0 and the string is converted
into the following form, “CCCCC(O)=C0”.We then create
LINGOs with the substring length of q = 4.
Once we extract the LINGOs from the SMILES
strings and retrieve their corresponding term frequencies
(Table 2), we calculate LINGOsim. We have nine unique























= 0 + 2 + 09 = 0.22
LINGO length q = 3, 4, 5 are tested in this work.
Table 2 LINGOs with their corresponding frequencies in the
sample SMILES strings SMI1 and SMI2
SMI1 SMI2
LINGO Freq LINGO Freq
OC(O 1 CCCC 2
C(O) 1 CCC( 1
(O)= 1 CC(O 1




LINGO based TF cosine similarity
Term-Frequency (TF) based cosine similarity is the first of
the weighting models that we adopted from the Informa-
tion Retrieval domain. TF reflects the number of times a
term occurs in a document [43]. Originally in TF weight-
ing, a weight representing the frequency of a term is
assigned to each term in the document. In this domain,
we treat each SMILES string as a document and four char-
acter LINGOs, which are created from these strings, are
denoted as terms. The TFweight of a LINGO L in SMILES




1 +log10(termfrequencyL,S), if termfrequencyL,S > 0
0, otherwise
In order to compute the similarity between two SMILES
strings using this method, each string has to be converted
into a feature vector Vs. The dimensionality of Vs is equal
to the number of unique terms (LINGOs) in the cor-
pus (compound data set). Each feature contains the TF
score of the corresponding term (LINGO) in the string
(SMILES). The similarity of two SMILES strings S1 and S2






VS1 and VS2 are feature vectors and m denotes the lengths
(L2 norm) of the vectors in Eq. 1 [44].
Let us demonstrate the computation of LINGO based
TF cosine similarity using the sample SMILES strings
SMI1 and SMI2, whose term frequencies are shown in
Table 2. Since we have nine unique LINGOs, the lengths of
the feature vectors are equal to nine, m = 9. Each dimen-
sion in the feature vector represents the term frequency
weight of the corresponding LINGO in the SMILES
strings. Thus, the feature vectors for SMI1 and SMI2 are
[1, 1, 1, 1, 0, 0, 0, 0, 0 ] and [0, 1, 1, 0, 1.3, 1, 1, 1, 1], respec-
tively for the following order of the LINGOs [OC(O, C(O),
(O)=, O)=O, CCCC, CCC(, CC(O, O)=C, )=C0]. Finally,






= (1 × 0)+
∑3





4 × (12) 2√6 × (12)+ 1.32
= 2/5.54 = 0.36
LINGO based TF-IDF cosine similarity
Term Frequency-Inverse Document Frequency (TF-IDF)
cosine similarity is the second model that we adopt
to measure compound similarity by utilizing SMILES
text. This method combines LINGO representation with
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the TF-IDF weighting-scheme. TF-IDF has originally
been developed in the Information Retrieval domain for
weighting the words in the documents just as TF weight-
ing. This method is especially useful for filtering or assign-
ing low weights to stop words such as ‘the’, ‘a’, and ‘an’.
Words are the terms of a document corpus and each docu-
ment is treated as a collection of terms (words). TF assigns
higher weights to those terms that occur frequently in a
document, IDF on the other hand, assigns higher weights
to the rare terms in the document collection. Terms that
are very common in the document collection are assumed
to have little discriminating power. IDF is described as,
idf (t,D) = log N|d∈D:t∈d| where t, D and N denote the
term, document corpus, and number of documents in
the corpus, respectively [45]. TF-IDF weighting is equal
to the product of term frequency and inverse document
frequency.
As shown in Eq. 1, the similarity between the feature
vectors is computed by using cosine similarity. Each fea-
ture now contains the TF-IDF score of the corresponding
term in the string. In this model, we treat each SMILES
string as a document that comprises a set of LINGOs, and
LINGOs are the terms of our system. LINGO length q is
selected as four as it is in the original algorithm.
Let us illustrate this model by using samples from the
compounds of the enzyme data set, which is one of the
benchmark data sets used in this study [5]. As shown
in Table 1, the enzyme data set comprises 445 different
compounds each represented as unique SMILES strings.
There are 1707 unique LINGOs created from 445 differ-
ent SMILES strings. In other words, it is a system of 445
documents and 1707 terms.
For instance, “O)CO” and “(=O)” are two LINGOs.
“(=O)” is a very frequent LINGO appearing in 300 out of
the 445 SMILES strings. Its IDF is 0.17 and therefore, this
LINGO can be considered as a stop word. “O)CO”, on the
other hand, is a rather rare LINGO, which is included in
only 18 SMILES strings. The IDF of this LINGO is 1.39.
The IDF weighting-scheme allows the model to assign
importance to the rare LINGOs. SMILES strings that
share infrequent LINGOs are favored and selected as
more similar in this model. After term frequencies and
IDFs of all the LINGOs are calculated, cosine similar-
ity is computed to measure the similarity between two
compounds.
Let us demonstrate the calculation of TF-IDF based
cosine similarity by using our sample SMILES strings
SMI1 and SMI2. The TF weights of the LINGOS in each
string are computed as described in the previous sub-
section (Section ‘LINGO based TF cosine similarity’). The
IDF scores of the LINGOs, which are computed by assum-
ing that the imaginary SMILES strings SMI1 and SMI2 are
compounds in the enzyme data set, are shown in Table 3.
Since the enzyme data set contains 445 compounds, the
Table 3 The IDF scores for the LINGOs in the sample imaginary
SMILES strings SMI1 and SMI2. The IDF scores are computed by
assuming that SMI1 and SMI2 are compounds in the enzyme data
set consisting of 445 compounds in total










numerator in the IDF formula is 445. For a LINGO L, the
denominator in the IDF formula is the number of com-
pounds in the enzyme data set that contain the LINGO L.
Thus, the TF-IDF weighted feature vectors for SMI1 and
SMI2 are [ 2.3, 0.5, 0.6, 0.4, 0, 0, 0, 0, 0 ] and [0, 0.5, 0.6,
0, 1.04, 0.9, 1, 2, 1.9], respectively. The cosine similarity






= 0 + (0.5 × 0.5) + (0.6 × 0.6) + 0 + 0 + 0 + 0 + 0 + 02√2.32+0.52+0.62+0.42 2√10.52+0.62+1.042+0.92+12+22+1.92
= 0.61/8.2 = 0.07
Composite kernels
Composite kernels are created by combining the similar-
ity matrices obtained from two different methods, namely
the 2D-based similarity function SIMCOMP and one of
our SMILES-based similarity functions. Scomposite, repre-
senting the similarity matrix of the composite kernel, is
derived by taking the unweighted average (i.e., λ = 0.5)
of the similarity matrix produced by SIMCOMP, Ssimcomp,
and the similarity matrix Sf produced by a SMILES-based
similarity function f,
Scomposite = λ ∗ Ssimcomp + (1 − λ) ∗ Sf
To obtain Sf , we experimented with our best perform-
ing SMILES-based similarity functions LINGO-based TF-
IDF cosine similarity and LINGOsim (q = 4).
Experiment setup
Experiments followed the procedure proposed by
Laarhoven [17]. For each interaction data set, five-fold
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cross validation is performed on the drug compounds.
In other words, the data sets are divided into five equal-
sized subsets and for each fold, one subset is used for
testing while the system is trained with the remaining
four subsets. This process is repeated five times.
Results and discussion
In this study, 13 different similarity kernels that utilize
SMILES (1D) representation of molecules are evaluated.
In order to assess the performances of these drug ker-
nels for the drug-target interaction prediction task, the
WNN-GIP approach is adopted. We compare the results
obtained using the SMILES representations of the com-
pounds with the 2D-based similarity method, SIMCOMP,
as well as two composite kernels formed by SIMCOMP
and a 1D-based similarity method. In the original appli-
cation of the WNN-GIP method, a compound simi-
larity matrix was computed by the 2D representation
based similarity method, SIMCOMP [17]. In this work,
the similarity matrix is computed by SIMCOMP or the
SMILES-based similarity functions. The compound sim-
ilarity matrix is then processed by WNN-GIP to predict
the protein-drug pairs in four different data sets. The
enzyme data is the largest data set with more than 400
drugs and 600 proteins, while the ion channel and GPCR
data sets are about half the size in terms of the number
of drugs, and the nuclear receptor data set is the smallest
with 54 drugs and 26 proteins.
A summary of the results for five-fold cross valida-
tion experiments for enzyme, ion channels, GPCR, and
nuclear receptors data sets are presented in Table 4. The
Table 4 Average AUC-ROC and AUC-PR scores for 5 repetitions
of 5 fold cv. on each of the four data sets. The standard deviations
are given in parenthesis
Method AUC-ROC (std) AUC-PR (std) Time (sec)
Enzyme
SIMCOMP 0.863 (0.016) 0.303 (0.027) 413,7 min
Edit 0.833 (0.016) 0.178 (0.004) 6
NLCS 0.837 (0.014) 0.228 (0.013) 4
CLCS 0.834 (0.013) 0.234 (0.019) 331
SMILES-based substring 0.752 (0.006) 0.169 (0.010) 133
SMIfp CBD (34D) 0.846 (0.009) 0.199 (0.008) 1
SMIfp Tanimoto (34D) 0.832 (0.012) 0.191 (0.012) 1
SMIfp CBD (38D) 0.852 (0.009) 0.205 (0.009) 1
SMIfp Tanimoto (38D) 0.844 (0.012) 0.201 (0.006) 1
LINGOsim (q=3) 0.846 (0.013) 0.290 (0.013) 3
LINGOsim (q=4) 0.823 (0.010) 0.294 (0.006) 3
LINGOsim (q=5) 0.819 (0.015) 0.264 (0.013) 3
LINGO-based TF 0.811 (0.017) 0.259 (0.008) 19
LINGO-based TF-IDF 0.822 (0.012) 0.292 (0.031) 47
TF-IDF+SIMCOMP 0.852 (0.010) 0.348 (0.017)a
LINGOsim+SIMCOMP 0.852 (0.016) 0.318 (0.019)a
Table 4 Average AUC-ROC and AUC-PR scores for 5 repetitions
of 5 fold cv. on each of the four data sets. The standard deviations
are given in parenthesis (Continued)
Ion Channels
SIMCOMP 0.776 (0.012) 0.224(0.032) 48,7 min
Edit 0.754 (0.013) 0.199 (0.025) 1
NLCS 0.753 (0.007) 0.189 (0.037) 0,9
CLCS 0.755 (0.018) 0.185 (0.028) 47
SMILES-based substring 0.743 (0.004) 0.197 (0.031) 21
SMIfp CBD (34D) 0.717 (0.019) 0.136 (0.036) 0,3
SMIfp Tanimoto (34D) 0.698 (0.015) 0.125 (0.022) 0,3
SMIfp CBD (38D) 0.722 (0.012) 0.137 (0.024) 0,3
SMIfp Tanimoto (38D) 0.699 (0.028) 0.156 (0.028) 0,4
LINGOsim (q=3) 0.737 (0.015) 0.192 (0.046) 0,8
LINGOsim (q=4) 0.737 (0.011) 0.197 (0.037) 1
LINGOsim (q=5) 0.727 (0.009) 0.188 (0.026) 1
LINGO-based TF 0.738 (0.018) 0.204 (0.024) 3
LINGO-based TF-IDF 0.712 (0.014) 0.178 (0.029) 7
TF-IDF+SIMCOMP 0.763 (0.010) 0.234 (0.017)
LINGOsim+SIMCOMP 0.773 (0.012) 0.229 (0.018)
GPCR
SIMCOMP 0.867 (0.009) 0.307 (0.018) 71,2 min
Edit 0.844 (0.015) 0.248 (0.030) 1
NLCS 0.853 (0.006) 0.247 (0.013) 1
CLCS 0.855 (0.014) 0.279 (0.030) 52
SMILES-based substring 0.782 (0.019) 0.205 (0.032) 21
SMIfp CBD (34D) 0.852 (0.014) 0.209 (0.018) 0,3
SMIfp Tanimoto (34D) 0.847 (0.006) 0.213 (0.016) 0,3
SMIfp Tanimoto (38D) 0.856 (0.009) 0.228 (0.015) 0,3
LINGOsim (q=3) 0.875 (0.003) 0.317 (0.015) 1
LINGOsim (q=4) 0.876 (0.004) 0.333 (0.020)a 1
LINGOsim (q=5) 0.874 (0.006)a 0.337 (0.019)a 1
LINGO-based TF 0.872 (0.004) 0.335 (0.012)a 3
LINGO-based TF-IDF 0.871 (0.007) 0.348 (0.018)a 9
TF-IDF+SIMCOMP 0.885 (0.006)a 0.371 (0.017)a
LINGOsim+SIMCOMP 0.879 (0.009)a 0.335 (0.016)a
Nuclear Receptors
SIMCOMP 0.856 (0.015) 0.435 (0.008) 2,9 min
Edit 0.828 (0.009) 0.305 (0.029) 0,2
NLCS 0.815 (0.018) 0.302 (0.032) 0,2
CLCS 0.813 (0.037) 0.319 (0.039) 10
SMILES-based substring 0.766 (0.028) 0.335 (0.035) 2
SMIfp CBD (34D) 0.809 (0.026) 0.296 (0.015) 0,1
SMIfp Tanimoto (34D) 0.784 (0.031) 0.281 (0.020) 0,1
SMIfp CBD (38D) 0.815 (0.017) 0.307 (0.024) 0,1
SMIfp Tanimoto (38D) 0.787 (0.030) 0.322 (0.034) 0,1
LINGOsim (q=3) 0.800 (0.013) 0.351 (0.036) 0,2
LINGOsim (q=4) 0.829 (0.013) 0.414 (0.031) 0,2
LINGOsim (q=5) 0.834 (0.013) 0.389 (0.023) 0,2
LINGO-based TF 0.820 (0.013) 0.373 (0.035) 0,4
LINGO-based TF-IDF 0.855 (0.022) 0.418 (0.016) 0,8
TF-IDF+SIMCOMP 0.861 (0.008) 0.436 (0.049)
LINGOsim+SIMCOMP 0.840 (0.015) 0.399 (0.031)
The best AUC-ROC and AUC-PR results for each data set are indicated in bold. The
results that are significantly better than SIMCOMP according to the paired t-test
(α = 0.05) are indicated witha . The p-values range between 0.0004 and 0.0329, and
they are provided in the Additional file 1: Table S1.
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performances of the methods are compared using the
Area Under the ROC Curve (AUC-ROC) and Area Under
the Precision-Recall curve (AUC-PR) metrics. AUC-ROC
presents the relation of True-Positive rate to the False-
Positive rate, whereas AUC-PR shows the proportion of
precision to recall. AUC-PR is favored when dealing with
unbalanced data sets with one class domination [46].
Protein-drug interaction data sets contain small number
of interacting pairs making them skewed.The AUC-ROC
and AUC-PR results, with standard deviations given in
parentheses, and the total time it takes to create a com-
pound similarity matrix for each kernel are tabulated.
The p-values for the statistical significance test compar-
ing each method and SIMCOMP are given in Additional
file 1: Table S1.
An overall comparison of the AUC-ROC values shows
that the 2D-based method SIMCOMP gives the best
results for the enzyme and ion channels data sets. The
edit distance performs as well as the other SMILES-
based methods, even though it is one of the most basic
approaches to measure similarity between two strings.
The SMILES-based substring kernel performs signifi-
cantly worse than the other kernels on the enzyme and
GPCR data sets. A detailed investigation of the results
obtained with each similarity method is presented below.
The NLCS and CLCS kernels perform close to the edit
distance. The CLCS, which combines three different mod-
ifications of the NLCS function, does not significantly
improve upon the original NLCS method for this domain.
CLCS achieves significantly better AUC-PR results than
NLCS only on the GPCR data set (p-value 0.019).
The original SMILES-based fingerprint approach
(SMIfp) converts SMILES representation into a 34D fin-
gerprint, where each dimension represents the frequency
of a pre-determined character for a given SMILES string.
In our study, we compared the frequent characters of our
compound data sets with the original 34 character list of
SMIfp. The comparison revealed that the characters ‘@’,
‘\’, ‘/’, ‘.’ which are ignored in the original SMIfp approach,
were among the most frequent characters in our data
sets. In addition, the ‘%’ character, which is listed as fre-
quent, was a rare character in our data set. ‘@’ and ‘@@’
characters give information on the chirality while ‘/’ and
‘\’ are the directional bonds. Therefore, we decided to
update the SMIfp design according to this information
by adding five more characters, ‘@’, ‘@@’, ‘.’, ‘\’, and ‘/’,
and removing ‘%’. As a result, we created a 38D SMIfp,
which was also tested with CBD and Tanimoto similarity
coefficient. Both AUC-ROC and AUC-PR results show
that 38D SMIfp performs significantly better than 34D
SMIfp on the enzyme data set (p-values 0.0007 and
0.0016, respectively) when used with CBD and on the
GPCR data set when used with Tanimoto (p-values 0.014
and 0.034, respectively). In addition, for 34D SMIfp, use
of CBD provides a statistically significant advantage over
Tanimoto on the enzyme and ion channels data sets in
terms of AUC-ROC score with p-values 0.014 and 0.032,
respectively.
LINGOsim (q = 4) produces significantly better AUC-
PR results than SIMCOMP with p-value 0.0017 on the
GPCR data set (Table 4). AUC-ROC results show that
LINGOsim with three character LINGO setting performs
better than with four and five character settings on the
enzyme data set, whereas setting substring length to five
works better on the nuclear receptors data set, suggesting
that the performance of LINGOsim with different sub-
string lengths depends on the data set. Therefore, we may
infer that it is better to test and see the best suitable setting
for each data set.
Both the SMILES-based substring kernel and the LIN-
GOsim kernels are based on partitioning the SMILES
string into substrings to calculate similarity. While the
LINGOsimmethod uses fixed length substrings, the other
uses all possible lengths of substrings starting with two
characters. The results show that use of different sub-
string lengths for LINGOsim does not drastically change
the results. Therefore, the success of LINGOsim over the
SMILES-based substring kernel may be due to the fact
that the SMILES-based substring kernel does not perform
length normalization.
LINGO-based TF-IDF cosine similarity kernel produces
significantly better AUC-PR results than SIMCOMP on
the GPCR data set with p-value 0.009. This approach uses
TF-IDF weighting and combines it with the LINGO rep-
resentation of SMILES. It treats each SMILES string as a
document and each LINGO in the SMILES is considered
as a term. TF weighting produces comparable AUC-ROC
and AUC-PR results with TF-IDF weighting for the GPCR
and enzyme data sets. In the Nuclear Receptors data
set, the TF-IDF based method performs significantly bet-
ter (p-value 0.033) than the TF based method in terms
of AUC-ROC scores, whereas in the Ion Channels data
set the TF-based method produces a significantly better
(p-value 0.030) AUC-ROC score than TF-IDF based
method. The better performance of TF-IDF weighting
over TF weighting suggests that, Nuclear Receptors data
set might contain some distinguishable LINGOs.
The application of the TF-IDF weighting also allows
us to further investigate the LINGO structures of each
compound data set based on their IDF values. LINGOs
with lower IDF values indicate that they are very common
in the SMILES strings for the given data sets, similar to
the stop words of a document corpus. Therefore, we list
and investigate the top ten LINGOs with the lowest IDF
values for each compound data set and provide the num-
ber of compounds they appear in Table 5. For instance,
“(=O)”, carboxyl group, is a common LINGO in all
data sets.
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Table 5 Top 10 most common LINGOs of each compound data
set
Enzyme/445 GPCR/223
LINGO Num. of drugs LINGO Num. of drugs
c0cc 321 c0cc 180
(=O) 300 0ccc 170
0ccc 279 (=O) 117
C(=O 228 cccc 108
ccc0 197 ccc0 107
cccc 171 ccc( 94
)c0c 155 C(=O 87
@H]( 149 )c0c 84
ccc( 144 Cc0c 78
[C@H 144 C(O) 72
Ion Channels/210 Nuclear Receptors/54
LINGO Num. of drugs LINGO Num. of drugs
c0cc 165 (=O) 37
0ccc 148 [C@H 35
(=O) 130 C@H] 35
ccc0 116 C(=O 35
cccc 105 H]0C 35
C(=O 101 [C@@ 35
)c0c 94 C@@H 35
ccc( 72 @@H] 35
O)c0 56 @H]0 35
=O)c 54 )[C@ 34
As shown in Table 5 more than half of the top-ten LIN-
GOs in the GPCR, enzyme, and ion channels data sets are
shared. On the other hand, the top-ten LINGOs in the
nuclear receptors data set are slightly different from these.
We observe that substrings of “[C@@H]” are common
LINGOs in the nuclear receptors data set. These symbols
indicate tetrahedral chirality in clockwise direction, for
example, at the Cα carbon of the peptide bond.
We also tested two composite kernels in which we
combine SIMCOMP with TF-IDF based cosine similarity
and LINGOsim (q=4). Combination of SIMCOMP with
TF-IDF based cosine similarity kernel produces the best
AUC-PR results on all data sets. It also has better AUC-
ROC scores amongst all other kernels on the GPCR and
nuclear receptors data sets.
Except for the ion channels data set, the SMILES-based
similarity methods perform almost as well as SIMCOMP,
a 2D-based method using graph representation to mea-
sure similarity. In terms of time complexity, all SMILES-
based methods perform significantly better than SIM-
COMP. For instance, on the GPCR data set, while it takes
more than an hour to compute the pairwise similarities
among the compounds using SIMCOMP, it only takes one
second when the LINGO kernel is used. Furthermore,
LINGO (q=4) manages to achieve a comparable AUC-PR
score with SIMCOMP, even though it only uses SMILES
to measure similarity.
The improvement of the TF-IDF/SIMCOMP composite
kernel over SIMCOMP, especially on the GPCR data set
with a statistical significance in terms of both AUC-ROC
and AUC-PR values (p-values 0.002 and 0.0005, respec-
tively), shows that the TF-IDF based cosine kernel might
be useful while combining different types of chemical
similarity kernels.
In order to illustrate the improvement of the compos-
ite kernel over SIMCOMP, let us investigate a case in
which an interaction was not predicted when SIMCOMP
was used, but was successfully predicted when the com-
posite kernel of SIMCOMP and TF-IDF was used: The
interaction of Adrenoceptor alpha 2A (hsa150) with Phen-
tolamine mesilate (D00509) (in the GPCR data set). The
SMILES string of Phentolamine mesilate contains some
rare LINGOs, namely “NCCN” and “=NCC” with IDF
values 1.8 and 1.9, respectively. Considering the IDF value
of 0.3 for the most frequent LINGO (“c0cc”) in the GPCR
data set, it becomes more apparent that these rare LIN-
GOs represent some specific features of a compound.
Further investigation of other drugs that interact with
Adrenoceptor alpha 2A shows that, Brimonidine tartrate
(D02076), also has the same two rare LINGOs and the
interaction with this drug is successfully predicted by the
composite kernel, but not by SIMCOMP alone. Similarly,
the interactions of Adrenoceptor alpha 2A with Clonidine
(D00281) and Clonidine hydrochloride (D00604), which
contain the “NCCN” LINGO are also predicted success-
fully by the composite kernel. Therefore, we can suggest
that these LINGOs reveal a pattern among the drugs
that bind to Adrenoceptor alpha 2A. The inclusion of the
TF-IDF kernel to the composite kernel helps us discover
hidden patterns by highlighting such rare LINGOs.
Conclusion
This work aims to provide a comparison of the avail-
able chemical similarity measurement methods that uti-
lize SMILES representation of molecules. The methods
presented here can be used in any model that requires
the computation of compound similarity. In this study, we
evaluated these methods using one of the state-of-the-art
approaches in the drug-target interaction prediction task,
namely WNN-GIP [17]. This model makes use of both
chemical similarity of compounds and sequence similar-
ity of proteins and is used on four different drug-protein
data sets proposed by Yamanishi and coworkers [5]. In
total, 13 string similarity functions including two novel
drug similarity methods adopted from the Information
Retrieval domain, namely cosine kernel with TF and TF-
IDF weighting are tested to assess their performances
in predicting protein-drug interactions. We also test two
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composite kernels created from SIMCOMP and two 1D
kernels, TF-IDF based cosine similarity and LINGOsim,
respectively. The results are compared with those found
using the 2D representation based method SIMCOMP.
With the WNN-GIP method, an adjacency matrix is
built using the bipartite drug-target interaction network.
This adjacency matrix and the compound chemical sim-
ilarity (calculated using the similarity kernels) and pro-
tein sequence similarity (calculated using the Smith-
Waterman algorithm) are combined to convert drugs and
targets into feature vectors. The bipartite drug-target
interaction network includes information on pairs that
are known to interact, but lacks information to differenti-
ate between inactives (known absence of interaction) and
untested compounds (absence of knowledge on interac-
tion) and the limitation expressed in Laarhoven et al.’s
work is present in this work as well [17]. The adjacency
matrix can be enriched by including information about
the strengths of the interactions in the form of IC50 values
to include inactives.
The comparison of the results using 1D-based sim-
ilarity methods with those found using the commonly
used 2D-based similarity kernel SIMCOMP shows that
the 1D-based methods of molecular similarity compar-
ison perform almost as well as the 2D-based meth-
ods in the protein-drug interaction task. However, when
the run times obtained using the two approaches are
compared, 2D representation based descriptors, which
use graph algorithms to compare similarity amongst
molecules, are computationally more complex than the
1D SMILES representation, which is a string of characters.
The experiments indicate that SMILES-based kernels are
significantly faster than the 2D-based SIMCOMP. Using
SMILES string as a molecular similarity kernel is not only
fast and straightforward, but also more flexible since any
string similarity algorithm can be applied to this repre-
sentation. Furthermore, 2D and 3D representation of a
molecule can be derived from its SMILES string by apply-
ing an efficient reconstruction algorithm [26]. Our study
shows that 1D SMILES representation based methods
perform close to SIMCOMP with significant computa-
tional flexibility and time advantage.
In this work inspired by the Information Retrieval
domain, we proposed the application of cosine similarity
with TF and TF-IDF weighting as novel ligand similar-
ity kernels. For the GPCR data set, AUC-PR results show
that the LINGO-based TF-IDF cosine similarity kernel
performs slightly better than SIMCOMP in the task of
protein-drug interaction prediction and LINGOsim with
q = 4 has comparable AUC-ROC results. Furthermore,
the composition of TF-IDF based cosine similarity ker-
nel with SIMCOMP proves to be promising given its
AUC-PR results are the best amongst all kernels. Use of
LINGO based TF-IDF weighting also allows identification
of differences in the distribution of LINGOs in the com-
pound data sets. It is observed that nuclear receptor drugs
differ from the other drugs in terms of common LINGOs.
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